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categories: genes with relative fold-change of mRNA less than 10
fold (A), genes with relative fold-change of mRNA between 10 and
100 fold (B), genes with relative fold-change of mRNA more than
100 fold (C).
Conclusions: These results indicated that resistin, the adipocyte-
derived cytokine, could be an important link between obesity and
osteoarthritic (OA) joint disease. Resistin is a proinﬂammatory
and destructive mediator of joint inﬂammation in human joint, and
might be considered as a potential therapeutical target in joint
degenerative diseases such as OA.
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SYNOVIUM, CARTILAGE AND HOFFA’S FAT PAD
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Purpose: Although osteoarthritis (OA) was originally described
as a noninﬂammatory arthropathy, inﬂammatory responses in syn-
ovium and cartilage may contribute to disease progression. Inﬂam-
mation is caused by direct biomechanical perturbation or reaction
to cartilage matrix degradation. Recent evidence has emerged for
a role of the Hoffa’s fat pad in the development and progression of
OA by the secretion of pro-inﬂammatory cytokines. The Hoffa’s fat
pad is located in the knee, intraarticular and extrasynovial, under
the patella.
Peroxisome Proliferator-Activated Receptorα (PPARα) is a mem-
ber of class I nuclear receptor superfamily of ligand-dependent
transcription factors. Anti-inﬂammatory effects of PPARα agonists
have been described in adipose tissue, liver, blood vessels, kidney,
macrophages and mesangial cells. We hypothesized that addition
of synthetic PPARα agonist Wy-14643 exerts anti-inﬂammatory
effects in OA joint tissues.
Methods: Explants of synovium (n=9), cartilage (n=9) and Hoffa’s
fat pad (n=10) were obtained from OA patients that underwent total
knee arthroplasty. Explants were cultured in DMEM-high glucose
with ITS, with(out) 100 μM PPARα agonist. 10 ng/ml Il-1β was
added as a pro-inﬂammatory stimulus. Gene expression analysis
was performed on cartilage explants (MMP1, MMP3, MMP13, ag-
grecan, collagen type II) and on synovium explants (MMP1, MMP3,
MMP13, Il-1β). The culture supernatant of cartilage and synovium
samples was analysed for NO production. Supernatant of cartilage
was analysed for GAG release. The culture supernatant of Hoffa’s
fat pad was analysed with ELISA for leptin, adiponectin, resistin,
MCP-1, TNFα, Il-1β, Il-6, Il-4 and Il-10. A decrease or increase
was deﬁned as more than 25 % of the control value. Results were
analysed with non-parametric tests.
Results: Addition of PPARα agonist decreased mRNA expression
of cartilage with 76 % for MMP1 (p=0.12), 68 % for MMP3 (p=0.02)
and 87 % for MMP13 (p=0.01). Addition of IL-1β decreased
collagen type II gene expression a 15-fold. Addition of the PPARα
agonist decreased this expression even more with 49% (p=0.02).
Aggrecan mRNA expression was not inﬂuenced by the PPARα
agonist. NO production of cartilage showed a trend towards a
decrease by the addition of PPARα agonist. The release of GAG
in cartilage culture supernatant was lower after addition of 100 μM
PPARα agonist (p=0.06).
A trend towards decrease could be observed for MMP1, MMP3
and MMP13 after adding PPARα agonist. Il-1β mRNA expression
and NO production by synovium was not inﬂuenced by the PPARα
agonist.
In culture supernatant of Hoffa’s fat pad, MCP-1 (p=0.01), Il-4
(p=0.03) and Il-10 (p=0.03) were decreased after adding PPARα
agonist. 7 donors showed a decrease and 2 an increase for TNFα
production (p=0.18). Leptin, resistin and Il-1β showed a trend
towards more donors with a decrease. Adiponectin and Il-6 were
not inﬂuenced.
Conclusions: Addition of 100 μM PPAR α agonist Wy-14643 de-
creased IL-1β induced MMP gene expression, NO production and
GAG release in cartilage and had an effect on collagen type II,
but not on aggrecan production. A non signiﬁcant decrease was
seen for MMP expression in synovium. The production of pro- and
anti-inﬂammatory cytokines by Hoffa’s fat pad was decreased by
adding 100 μM PPAR α agonist. In general, the use of PPAR α
agonist Wy-14643 showed promising results in inhibiting inﬂam-
matory processes in OA joint tissues. The use of these synthetic
ligands for treatment of OA should be further explored.
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Purpose: It has been suggested that many cases of primary hip
OA are actually caused by mild morphological variations in the
shape of the hip. Interestingly, genes that have been found to
affect susceptibility for OA such as FRZB, GDF5 and DIO2, are
involved in endochondral ossiﬁcation and regulate the process of
skeletal formation.
In this study, we have quantiﬁed the shape of the hip in sibling
pairs of the GARP study, who have symptomatic OA at multiple
joint locations. We estimated familial aggregation of hip shape and
investigated whether shape is affected by the genetic variation at
the OA susceptibility genes.
Methods: A Statistical Shape Model was created of the shape
of the proximal femur and pelvis of radiographs of the hips of
sibling pairs of the GARP study. The method results in a set
of independent modes that together quantitatively describe the
total shape, while each mode separately describes a speciﬁc
characteristic of the shape. This preliminary data concerns 74
sibling pairs (148 subjects), of which 29 subjects had radiographic
signs of hip OA (KL>1). Familial aggregation (heritability) of shape
was estimated from the variance within and between siblings.
Associations between shape and SNPs of the FRZB, GDF5 and
DIO2 genes were tested using mixed model regression with height,
gender, age, BMI, and OA status (KL>1 for 0, 1 or 2 hips) as
co-variables. In these analyses we modeled familial and left and
right hip dependencies through random effect variables.
Results: 5 out of 30 modes showed signiﬁcant familial aggregation
describing over 60% of the total variation in shape. OA status
associated signiﬁcantly with femurs with a stocky appearance
(mode 6, p=0.03), a short superior neck (mode 11, p=0.002)
and a small offset between superior neck and head (mode 17,
p=0.035). It is unclear whether these associations are the result
of the OA disease process or point to a factor underlying the OA
process. Modes 5 (p=0.012) and 16 (p=0.004) showed a dose
response association with respectively DIO2 OA susceptibility
SNPs rs225014 and rs12885300. Both modes are descriptors of
acetabular shape. Mode 3 associated signiﬁcantly (p=0.002) with
the FRZB SNP rs388326 and describes the slenderness of femur
and pelvis (see Figure 1 for modes 3 and 5). No associations were
found for GDF5.
Conclusions: These initial analyses showed that a large part of
the variation in hip shape is attributable to familial aggregation
(>60%) which reﬂects both shared genetic and environmental
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Figure 1
factors. The heritable modes concern the more overall variations
in shape, like slenderness of the hips, suggesting that subtle
shape variations are due to individual environmental factors.
Two of the tested OA susceptibility genes associated with varia-
tions in hip shape. FRZB, part of the ubiquitous and for cartilage
and bone highly relevant Wnt-signaling pathway, associated with
an overall change in shape, ranging from broad to slender hips.
The inﬂuence of the DIO2 variant on mode 5 appears to link
OA susceptibility to shallow placement of the head inside the
acetabulum, which resembles dysplasia and has previously been
recognized as a predisposing factor of OA.
Although independent of OA status, this data shows that SNPs of
the tested genes are indeed associated with variations in shape
of the hip.
Aging
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BACKGROUND OF GENERALIZED OSTEOARTHRITIS;
EPIDEMIOLOGICAL ANALYSIS OF THE DISTRIBUTION OF
PERI-ARTICULAR OSTEOPHYTES IN HUMAN SKELETONS
T. Tsurumoto, A. Yonekura, S. Kajiyama, H. Shindo
Nagasaki Univ., Nagasaki, Japan
Purpose: The concept of generalized osteoarthritis (GOA) was
ﬁrstly deﬁned by Kellgren and Moore (1952). Peri-articular osteo-
phyte is one of the typical features of joint degeneration; such
osteophytes emerge with ageing and develop as the pathological
condition of osteoarthritis progresses. By analyzing the distribu-
tion of these minor degenerative and proliferative phenomena in
general skeletal systems, considerable information on physiologi-
cal and/or pathological ageing, and the background of GOA was
derived.
Methods: Three hundred and seventy Japanese skeletons (male
232 and female 138) were examined. All of the six major joints,
shoulder, elbow, wrist, hip, knee and ankle in every skeleton were
observed macroscopically. Broken parts of the joint surfaces were
not evaluated; accordingly 180 skeletons were scored in all of
these six joints (male 122 and female 58). Materials ranged from
19 to 92 years of age at the time of death, and the average was
59.7 years old for males and 66.2 years old for females; the latter
was signiﬁcantly higher than that of the former. Using our criteria,
the osteophytes were estimated as grade 0, 1, 2, 3 or 4 based on
size and degree of proliferation in order to determine osteophyte
scores (OS) from 0 to 50 in every skeleton. The scores for
the upper extremity (UOS) were calculated by averaging scores
for shoulder, elbow and wrist joints in every skeleton; and the
scores for the lower extremity (LOS) were calculated by averaging
the scores for hip, knee and ankle joints. Averages of all six
joint scores in every skeleton were calculated to obtain its total
osteophyte scores (TOS).
Results: The values for UOS and LOS showed signiﬁcant corre-
lation. The correlation coefﬁcient in males was 0.78, which was
larger than that in females, 0.63. In females, it was noted that the
score for LOS was relatively higher than that for UOS, and there
were many individuals in whom LOS was higher than those of
UOS. In males, there were many individuals in whom UOS was
relatively higher than those of LOS (Fig. 1). Fig. 2 is the scatter
chart in which TOS was plotted as the longitudinal axis and age
as the horizontal axis, and the correlation coefﬁcients between
TOS and age in males and females were determined. This chart
shows that the average scores for males were larger than those for
females but the rate of increase in females was greater than that
in males. In males, the correlation coefﬁcient between the TOS
and age was 0.59, and in females, that was 0.70.There were some
individuals whose TOS was uncharacteristically larger or smaller
for their age; especially several males younger than 60 years old
and several female older than 60 years old showed higher than
expected OS for their age.
Figure 1
Figure 2
Conclusions: The development of the osteophyte formations is
affected by various factors: both systemic conditions and local
environment. This study reassessed the potential inﬂuence of the
unequal distribution of mechanical stress on joint surfaces in the
facilitation of osteophytes formation and osteoarthritis pathogen-
esis; for example, UOS was relatively high in males, and LOS
was relatively high in females. Though it was quite difﬁcult to
distinguish the GOA skeletons based on the values of OS alone, it
was shown that OS of some skeletons were higher than expected,
